Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S, F.C.P.S, F.P.S.I.M, C.H.P.E, M.A.C.G
Internal Medicine Specialist
M.B.B.S., MRCGP (UK)
General Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, FACP (USA), FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS, M.C.P.S
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP (UK), Fellow Rheumatology
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCPS (Glasg), Fellow Critical Care Medicine, MACP (USA), MPSIM (PAK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCPS (Glasg), Fellow Critical Care Medicine, MACP (USA), MPSIM (PAK)
Internal Medicine Specialist
MBBS, MD, MCPS
Consultant Physician
MBBS, FCPS, MRCP
Internal Medicine Specialist
M.B.B.S., F.C.P.S., M.R.C.P. (UK)*
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures